MDR-TB threatens TB control programs in Australia’s region and will not diminish without concerted efforts
Tuberculosis (TB) is one of the world’s great killers, but Australia has been relatively protected because of its strong public health system. Of 1300 cases reported in Australia each year, almost 90% occur in the overseas born, although Indigenous Australians are also disproportionately affected. Most cases arise in the large immigrant communities from India, Vietnam, the Philippines, China and Nepal, but high rates are also reported from Papua New Guinea (PNG), Ethiopia, Somalia and Myanmar. These cases occur primarily in permanent residents and students, rather than in refugees or those on humanitarian visas.1
- 1. Toms C, Stapledon R, Waring J, Douglas P, National Tuberculosis Advisory Committee. Tuberculosis notifications in Australia, 2012 and 2013. Commun Dis Intell 2015; 39: E217-E235. https://www.health.gov.au/internet/main/publishing.nsf/Content/cda-cdi3902-pdf-cnt.htm/$FILE/cdi3902f.pdf (accessed Mar 2016).
- 2. World Health Organization. Global tuberculosis report 2015. http://www.who.int/tb/publications/global_report/gtbr15_main_text.pdf?ua=1 (accessed Mar 2016).
- 3. McBryde ES. Evaluation of risks of tuberculosis in Western Province Papua New Guinea. Melbourne: Burnet Institute, 2012.
- 4. Kirby T. Extensively drug-resistant tuberculosis hovers threateningly at Australia’s door. Med J Aust 2013; 198: 355. <MJA full text>
- 5. Falzon D, Gandhi N, Migliori GB, et al. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur Respir J 2013; 42: 156-168.
- 6. Migliori GB, Sotgiu G, Gandhi NR, et al. Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis. Eur Respir J 2013; 42: 169-179.
- 7. Van Deun A, Maug AK, Salim MA, et al. Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2010; 182: 684-692.
- 8. Marks SM, Flood J, Seaworth B, et al. Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005–2007. Emerg Infect Dis 2014; 20: 812-821.
- 9. Kendall EA, Fofana MO, Dowdy DW. Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis. Lancet Respir Med 2015; 3: 963-972.
- 10. Trauer JM, Denholm JT, Waseem S, Ragonnet R, McBryde ES. Scenario analysis for programmatic tuberculosis control in Western Province, Papua New Guinea. Am J Epidemiol 2015. In press.
- 11. US Government. National action plan for combating multidrug-resistant tuberculosis: Washington, DC: The White House, 2015. https://www.whitehouse.gov/sites/default/files/microsites/ostp/national_action_plan_for_tuberculosis_20151204_final.pdf (accessed Mar 2016).
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.